Incyte Corporation (NASDAQ: INCY) stock closed at 74.34 per share at the end of the most recent trading day (a 1.29% change compared to the prior day closing price) with a volume of 1.38M shares and market capitalization of 16.59B. Is a component of S&P 500, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 1773 people. Incyte Corporation CEO is Herve Hoppenot.

The one-year performance of Incyte Corporation stock is -10.98%, while year-to-date (YTD) performance is 1.28%. INCY stock has a five-year performance of -43.44%. Its 52-week range is between 61.91 and 88.26, which gives INCY stock a 52-week price range ratio of 49.22%

Incyte Corporation currently has a PE ratio of 17.80, a price-to-book (PB) ratio of 4.29, a price-to-sale (PS) ratio of 5.30, a price to cashflow ratio of 21.90, a PEG ratio of 2.32, a ROA of 21.92%, a ROC of 27.97% and a ROE of 28.98%. The company’s profit margin is 29.77%, its EBITDA margin is 20.40%, and its revenue ttm is $3.11 Billion , which makes it $14.06 revenue per share.

Of the last four earnings reports from Incyte Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.34 for the next earnings report. Incyte Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Incyte Corporation is Moderate Buy (2), with a target price of $87.42, which is +16.75% compared to the current price. The earnings rating for Incyte Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Incyte Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Incyte Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 12.08, ATR14 : 2.32, CCI20 : -99.46, Chaikin Money Flow : 0.07, MACD : -0.85, Money Flow Index : 45.87, ROC : -3.68, RSI : 45.42, STOCH (14,3) : 23.58, STOCH RSI : 0.55, UO : 48.52, Williams %R : -76.42), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Incyte Corporation in the last 12-months were: Barry P. Flannelly (Option Excercise at a value of $2 950 627), Barry P. Flannelly (Sold 43 993 shares of value $3 672 887 ), Dashyant Dhanak (Sold 1 569 shares of value $123 387 ), Jonathan Elliott Dickinson (Sold 7 375 shares of value $547 151 ), Maria E. Pasquale (Option Excercise at a value of $41 634), Paul Trower (Option Excercise at a value of $601 347), Paul Trower (Sold 8 214 shares of value $602 168 ), Paula J. Swain (Option Excercise at a value of $1 577 309), Paula J. Swain (Sold 20 189 shares of value $1 481 453 ), Vijay K. Iyengar (Sold 4 911 shares of value $384 482 ), Wendy L. Dixon (Option Excercise at a value of $1 465 000), Wendy L. Dixon (Sold 20 000 shares of value $441 000 ), Wenqing Yao (Sold 27 194 shares of value $2 321 551 )